Health

AstraZeneca Heart Disease Trial Failure Sparks Concern

Updated 2026-08-28 09:40 UTC 1 source Negative

AstraZeneca disclosed the failure of a major heart disease trial, raising questions about silencer drugs in a competitive market. The study's outcome could impact future research and drug development.

Coverage timeline — 1 article

STAT News

STAT+: In autopsy of failed heart disease study, AstraZeneca raises broader questions about silencer drugs

AstraZeneca detailed the surprise failure of a closely watched heart disease trial, a study with ripple effects for a competitive billion-dollar market.

2026-08-28 09:23 UTC